ChatGJP “Metabolomics for responder/non-responder identification”
Welcome to Panome Bio’s ChatGJP series with CSO Gary J. Patti, Ph.D. In this session, we ask Dr. Patti, “How is metabolomics being used to identify responder and non-responder populations in clinical trials?”
Have a Question?
Your privacy is important to us.
We’ll never share your information.